Article Details
Retrieved on: 2023-12-08 22:37:44
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Point Biopharma, Oncology, Clinical, $1.4 billion, $12.50, 87%. 7/28/23, Biogen, Reata Pharmaceuticals, Neurology, Commercial, $7.3 billion, $172.50.
Article found on: www.fool.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here